N6-Cyclopentyladenosine
Chemical compound / From Wikipedia, the free encyclopedia
N6-Cyclopentyladenosine (CPA) is a drug which acts as a selective adenosine A1 receptor agonist.[1] It has mainly cardiovascular effects with only subtle alterations of behavior.[2] CPA is widely used in scientific research into the adenosine receptors and has been used to derive a large family of derivatives.[3][4][5][6][7]
Quick Facts Names, Identifiers ...
Names | |
---|---|
IUPAC name
N6-Cyclopentyladenosine | |
Systematic IUPAC name
(2R,3R,4S,5R)-2-[6-(Cyclopentylamino)-9H-purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol | |
Identifiers | |
3D model (JSmol) |
|
ChemSpider |
|
PubChem CID |
|
UNII | |
CompTox Dashboard (EPA) |
|
| |
| |
Properties | |
C15H21N5O4 | |
Molar mass | 335.364 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Close